These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36229645)

  • 1. Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer.
    Jiang YF; Wei SN; Geng N; Qin WW; He X; Wang XH; Qi YP; Song S; Wang P
    Sci Rep; 2022 Oct; 12(1):17201. PubMed ID: 36229645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two microRNAs of plasma-derived small extracellular vesicles as biomarkers for metastatic non-small cell lung cancer.
    Geng N; Qi Y; Qin W; Li S; Jin H; Jiang Y; Wang X; Wei S; Wang P
    BMC Pulm Med; 2023 Jul; 23(1):259. PubMed ID: 37452310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.
    Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A
    J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules.
    Zheng D; Zhu Y; Zhang J; Zhang W; Wang H; Chen H; Wu C; Ni J; Xu X; Nian B; Chen S; Wang B; Li X; Zhang Y; Zhang J; Zhong W; Xiong L; Li F; Zhang D; Xu J; Jiang G
    J Nanobiotechnology; 2022 Apr; 20(1):172. PubMed ID: 35366907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.
    Petracci E; Pasini L; Urbini M; Felip E; Stella F; Davoli F; Salvi M; Beau-Faller M; Tebaldi M; Azzali I; Canale M; Solli P; Lai G; Amat R; Carbonell C; Falcoz PE; Martinez-Marti A; Pencreach E; Delmonte A; Crinò L; Ulivi P
    J Exp Clin Cancer Res; 2024 Aug; 43(1):241. PubMed ID: 39169404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
    Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
    BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
    Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C
    Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor-Draining Vein Identifies miR-203a-3p as a Relapse Biomarker for Resected Non-Small Cell Lung Cancer.
    Han B; Molins L; He Y; Viñolas N; Sánchez-Lorente D; Boada M; Guirao A; Díaz T; Martinez D; Ramirez J; Moisés J; Acosta-Plasencia M; Monzo M; Marrades RM; Navarro A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
    O'Farrell HE; Bowman RV; Fong KM; Yang IA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
    Dong X; Chang M; Song X; Ding S; Xie L; Song X
    Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.